Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
about
Sex differences in the pathophysiology, treatment, and outcomes in IHDThe Role of Cardiac MRI in Patients with Troponin-Positive Chest Pain and Unobstructed Coronary Arteries.Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease.Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart SurveyNonobstructive coronary artery disease and risk of myocardial infarctionAngina Frequency After Acute Myocardial Infarction In Patients Without Obstructive Coronary Artery Disease.Nonatherosclerotic causes of acute coronary syndrome: recognition and management.Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.MRI in the assessment of ischaemic heart disease.Personality subtypes and chest pain in patients with nonobstructive coronary artery disease from the TweeSteden Mild Stenosis study: mediating effect of anxiety and depression.Acute Coronary Syndromes: Differences in Men and Women.Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Women Versus Men: Long-Term Outcomes From the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter) Registry.Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging.Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.Variations in Use of Optimal Medical Therapy in Patients With Nonobstructive Coronary Artery Disease: A Population-Based Study.Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).Is non-obstructive coronary artery disease clinically important?Stress Cardiac MRI in Women With Myocardial Infarction and Nonobstructive Coronary Artery Disease.Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease.Impact of clinical presentation and presence of coronary sclerosis on long-term outcome of patients with non-obstructive coronary artery diseaseIschemia and No Obstructive Coronary Artery Disease ( INOCA ): What Is the Risk?
P2860
Q28084204-BE288D76-A327-42C8-88C5-F11FF5AB0A16Q35789203-041705C4-036F-4EE8-A16A-4B0C41F323F1Q36747886-B180FACB-C514-406F-BD56-C4B2333694C9Q36836426-38C93E69-B7F2-4A35-BAB7-450A2CF7FAD2Q36969333-45F17A5B-8272-4314-8120-9FE5962ECAF2Q37660304-27A4344A-4DBF-4378-A6D5-E003E50FED2AQ38259447-BE8B4449-0875-4FE9-944C-22B917FA9F76Q38589870-BB7B90AB-9BCC-4E21-A001-3A1AC1F160C0Q38683717-4088A979-43E4-447D-A9A9-66F92768CFA3Q38992268-7C1EBE34-BB76-47F9-AE05-2CE92784D397Q38997170-FCF81953-16AD-4E64-81B9-56C952F893AEQ40090120-3203AB59-FABA-4082-A31D-E5F6687FBDC4Q40293985-6E74EAE1-0CAB-4B4E-8AEF-513D571CB808Q41173387-0B57B813-9449-4081-834A-DB5994DB4B1CQ47098504-A8383E86-D7F4-449B-8228-C36D3080EB58Q47348124-6668A5FD-E7BB-4C90-BB5F-2AC418015277Q48670863-86E7B13F-33AE-4756-9AAD-833FA90CE1BFQ52673741-32C498ED-1A3F-4ACA-B068-5E599B4045C8Q53808591-D7725335-AF71-4DE7-A4A6-44396CD2110FQ57167927-AA64326D-A990-4300-94F4-5F95ED08C2C0Q58127359-7604775B-A6DF-4B4D-982E-CFF051459FF5
P2860
Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@ast
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@en
type
label
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@ast
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@en
prefLabel
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@ast
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@en
P2093
P1476
Utilization of secondary preve ...... ta Registry Cath-PCI Registry.
@en
P2093
John S Rumsfeld
P Michael Ho
Thomas M Maddox
Thomas T Tsai
P304
P356
10.1161/CIRCOUTCOMES.109.906214
P577
2010-10-05T00:00:00Z